Condition
Rejection; Transplant, Liver
Total Trials
4
Recruiting
3
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Recruiting3
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05234190Phase 1Active Not RecruitingPrimary
Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients
NCT04838171Recruiting
Prospective Study of White Blood Cells
NCT06734013Not ApplicableRecruitingPrimary
Transcriptomics as an Aid in the Histological Diagnosis of Acute Rejection After Liver Transplantation
NCT06717542Not ApplicableRecruiting
Tissue Analysis of Liver Grafts as a Predictor of Transplant Outcome.
Showing all 4 trials